Transgenic Mice Overexpressing Glycogen Synthase Kinase 3β: A Putative Model of Hyperactivity and Mania
Open accessAbstract
Lithium is used as treatment for bipolar disorder with particular efficacy in the treatment of mania. Lithium inhibits glycogen synthase kinase 3beta (GSK-3beta) directly or indirectly via stimulation of the kinase Akt-1. We therefore investigated the possibility that transgenic mice overexpressing GSK-3beta could be of relevance to model bipolar disorder. Transgenic mice showed hypophagia, an increased general locomotor activity, and decreased habituation as assessed in an open field, an increased acoustic startle response, and again decreased habituation. The forced swim test revealed a reduced immobility in transgenic mice, but this is probably related to the hyperactivity of the animals. There were no differences in baseline and stress-induced increases of plasma adrenocorticotrophic hormone and corticosterone levels. Molecular analysis suggests compensatory mechanisms in the striatum of these transgenic mice for the overload of active GSK-3beta by dimming the endogenous GSK-3beta signaling pathway via upregulation of Akt-1 expression. Brain-derived neurotrophic factor protein levels were increased in the hippocampus of the transgenic mice. This suggests some kind of compensatory mechanism to the observed reduction in brain weight, which has been related previously to a reduced size of the somatodendritic compartment. Together, in mice overexpressing GSK-3beta, specific intracellular signaling pathways are affected, which is accompanied by altered plasticity processes and increased activity and reactivity, whereas habituation processes seem to be decreased. The behavioral observations led to the suggestion that the model at hand recapitulates hyperactivity as observed in the manic phase of bipolar disorder.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Transgenic mice overexpressing GSK3β are hyperactive.
“transgenic mice overexpressing the circadian modulator, GSK3β, are hyperactive, have reduced immobility in the forced swim test (indicative of lower depression-like behavior), and an increased startle response (Prickaerts et al., 2006).”
From Circadian genes, rhythms and the biology of mood disorders (2007) · cites this paper as Prickaerts et al., 2006
Transgenic mice overexpressing GSK3β have an increased startle response.
“transgenic mice overexpressing the circadian modulator, GSK3β, are hyperactive, have reduced immobility in the forced swim test (indicative of lower depression-like behavior), and an increased startle response (Prickaerts et al., 2006).”
From Circadian genes, rhythms and the biology of mood disorders (2007) · cites this paper as Prickaerts et al., 2006
Transgenic mice overexpressing GSK3β have reduced immobility in the forced swim test.
“transgenic mice overexpressing the circadian modulator, GSK3β, are hyperactive, have reduced immobility in the forced swim test (indicative of lower depression-like behavior), and an increased startle response (Prickaerts et al., 2006).”
From Circadian genes, rhythms and the biology of mood disorders (2007) · cites this paper as Prickaerts et al., 2006
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244 · see citing works
Mechanism of activation of protein kinase B by insulin and IGF‐1.
Alessi, D. R., Andjelković, M., Caudwell, B., Cron, P. D., MORRICE, N. A., Cohen, P., & Hemmings, B. A. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01045.x · Cited by 2,985 · see citing works
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996) · Nature · doi:10.1038/379606a0 · Cited by 2,476 · see citing works
A molecular mechanism for the effect of lithium on development.
Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,305 · see citing works
GSK-3: tricks of the trade for a multi-tasking kinase
Doble, B. W., & Woodgett, J. R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00384 · Cited by 2,084 · see citing works
GSK3 takes centre stage more than 20 years after its discovery
FRAME, S., & COHEN, P. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3590001 · Cited by 1,433 · see citing works
The multifaceted roles of glycogen synthase kinase 3β in cellular signaling
Grimes, C. A., & Jope, R. S. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00011-9 · Cited by 1,429 · see citing works
Koch, M. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00098-7 · Cited by 1,287 · see citing works
Nibuya, M., Nestler, E., & Duman, R. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-07-02365.1996 · Cited by 1,206 · see citing works
Prestimulus Effects on Human Startle Reflex in Normals and Schizophrenics
BRAFF, D. L., Stone, C., Callaway, E., Geyer, M. A., Glick, I. D., & Bali, L. (1978) · Psychophysiology · doi:10.1111/j.1469-8986.1978.tb01390.x · Cited by 1,171 · see citing works
Neural and developmental actions of lithium: A unifying hypothesis
Berridge, M. J., Downes, C. P., & Hanley, M. R. (1989) · Cell · doi:10.1016/0092-8674(89)90026-3 · Cited by 1,016 · see citing works
An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior
Beaulieu, J., Sotnikova, T. D., Marion, S., Lefkowitz, R. J., Gainetdinov, R. R., & Caron, M. G. (2005) · Cell · doi:10.1016/j.cell.2005.05.012 · Cited by 980 · see citing works
Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia
Emamian, E. S., Hall, D., Birnbaum, M. J., Karayiorgou, M., & Gogos, J. A. (2004) · Nature Genetics · doi:10.1038/ng1296 · Cited by 914 · see citing works
Role of Serotonin in the Paradoxical Calming Effect of Psychostimulants on Hyperactivity
Gainetdinov, R. R., Wetsel, W. C., Jones, S. R., Levin, E. D., Jaber, M., & Caron, M. G. (1999) · Science · doi:10.1126/science.283.5400.397 · Cited by 885 · see citing works
Beaulieu, J., Sotnikova, T. D., Yao, W., Kockeritz, L. K., Woodgett, J. R., Gainetdinov, R. R., & Caron, M. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307921101 · Cited by 792 · see citing works
Greengard, P., Allen, P. B., & Nairn, A. C. (1999) · Neuron · doi:10.1016/s0896-6273(00)80798-9 · Cited by 748 · see citing works
Beck, K. D., Powell-Braxtont, L., Widmer, H.-R., Valverde, J., & Hefti, F. (1995) · Neuron · doi:10.1016/0896-6273(95)90216-3 · Cited by 636 · see citing works
Enhancement of Hippocampal Neurogenesis by Lithium
Chen, G., Rajkowska, G., Du, F., Seraji‐Bozorgzad, N., & Manji, H. K. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751729.x · Cited by 601 · see citing works
Andjelkovic, M., Jakubowicz, T., Cron, P., Ming, X., Han, J. W., & Hemmings, B. (1996) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.93.12.5699 · Cited by 525 · see citing works
Psychiatric and Medical Comorbidities of Bipolar Disorder
Krishnan, K. R. R. (2005) · Psychosomatic Medicine · doi:10.1097/01.psy.0000151489.36347.18 · Cited by 502 · see citing works
Both the Establishment and the Maintenance of Neuronal Polarity Require Active Mechanisms
Jiang, H., Guo, W., Liang, X., & Rao, Y. (2005) · Cell · doi:10.1016/j.cell.2004.12.033 · Cited by 494 · see citing works
Hyperactivity and impaired response habituation in hyperdopaminergic mice
Zhuang, X., Oosting, R. S., Jones, S. R., Gainetdinov, R. R., Miller, G. W., Caron, M. G., & Hen, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1982 · Cited by 493 · see citing works
Insulin Activation of Phosphatidylinositol 3-Kinase in the Hypothalamic Arcuate Nucleus
Niswender, K. D., Morrison, C. D., Clegg, D. J., Olson, R., Baskin, D. G., Myers, M. G., Seeley, R. J., & Schwartz, M. W. (2003) · Diabetes · doi:10.2337/diabetes.52.2.227 · Cited by 476 · see citing works
Glycogen Synthase Kinase-3: a Putative Molecular Target for Lithium Mimetic Drugs
Gould, T. D., & Manji, H. K. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300731 · Cited by 377 · see citing works
Wagner, J. P., Black, I. B., & DiCicco-Bloom, E. M. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-14-06006.1999 · Cited by 373 · see citing works
Lithium Induces Rapid Relief of Depression in Tricyclic Antidepressant Drug Non-Responders
de Montigny, C., Grünberg, F., Mayer, A., & Deschenes, J.-P. (1981) · The British Journal of Psychiatry · doi:10.1192/bjp.138.3.252 · Cited by 367 · see citing works
Spittaels, K., den Haute, C. V., Dorpe, J. V., Geerts, H., Mercken, M. H., Bruynseels, K., Lasrado, R., Vandezande, K., Laenen, I., Boon, T., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006219200 · Cited by 317 · see citing works
Gould, T. D., Einat, H., Bhat, R. V., & Manji, H. K. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004535 · Cited by 314 · see citing works
The role of dopamine in the mechanism of action of antidepressant drugs
D’Aquila, P. S., Collu, M., Gessa, G. L., & Serra, G. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00566-5 · Cited by 290 · see citing works
Kaidanovich‐Beilin, O., Milman, A., Weizman, A., Pick, C. G., & Eldar-Finkelman, H. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.01.008 · Cited by 276 · see citing works
Ralph, R. J., Paulus, M. P., Fumagalli, F., Caron, M. G., & Geyer, M. A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-01-00305.2001 · Cited by 271 · see citing works
Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania
Perry, W., Minassian, A., Feifel, D., & Braff, D. L. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01184-2 · Cited by 260 · see citing works
Glycogen synthase kinase‐3β, mood stabilizers, and neuroprotection
Li, X., Bijur, G. N., & Jope, R. S. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.2002.40201.x · Cited by 238 · see citing works
Swerdlow, N. R., Mansbach, R. S., Geyer, M. A., Pulvirenti, L., Koob, G. F., & BRAFF, D. L. (1990) · Psychopharmacology · doi:10.1007/bf02244616 · Cited by 235 · see citing works
In Vivo Evidence in the Brain for Lithium Inhibition of Glycogen Synthase Kinase-3
Gould, T. D., Chen, G. J., & Manji, H. K. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300283 · Cited by 217 · see citing works
Insulin-like growth factor 1 regulates developing brain glucose metabolism
Cheng, C. M., Reinhardt, R. R., Lee, W.-H., Joncas, G., Patel, S. C., & Bondy, C. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.170008497 · Cited by 204 · see citing works
BDNF‐mediated signal transduction is modulated by GSK3β and mood stabilizing agents
Mai, L., Jope, R. S., & Li, X. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00939.x · Cited by 195 · see citing works
Body weight is regulated by the brain: a link between feeding and emotion
Kishi, T., & Elmquist, J. K. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001638 · Cited by 178 · see citing works
Jacobsen, J. P. R., & Mørk, A. (2004) · Brain Research · doi:10.1016/j.brainres.2004.07.065 · Cited by 177 · see citing works
Glucocorticoids and depression
Steckler, T., Holsboer, F., & Reul, J. M. H. M. (1999) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.1999.0046 · Cited by 160 · see citing works
Perspectives for the development of animal models of bipolar disorder
Machado-Vieira, R., Kapczinski, F., & Soares, J. C. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2003.10.015 · Cited by 158 · see citing works
Gould, T. D., Zarate, C. A., & Manji, H. K. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0103 · Cited by 156 · see citing works
Novelty Seeking and Stereotypic Activation of Behavior in Mice with Disruption of the Dat1 Gene
Pogorelov, V. M., Rodriguiz, R. M., Insco, M. L., Caron, M. G., & Wetsel, W. C. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300724 · Cited by 151 · see citing works
Glycogen Synthase Kinase 3: A Target for Novel Mood Disorder Treatments
Gould, T. D., & Manji, H. K. (2006) · doi:10.1002/0470052171.ch7 · Cited by 135 · see citing works
Role of dopamine in prepulse inhibition of acoustic startle
Zhang, J., Forkstam, C., Engel, J., & Svensson, L. (2000) · Psychopharmacology · doi:10.1007/s002130000369 · Cited by 129 · see citing works
A concise review on the therapeutics of obesity
Bray, G. A. (2000) · Nutrition · doi:10.1016/s0899-9007(00)00424-x · Cited by 129 · see citing works
Ralph, R. J., Paulus, M. P., Zhuang, X., Hen, R., & Geyer, M. A. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01489-0 · Cited by 119 · see citing works
Spittaels, K., den Haute, C. V., Dorpe, J. V., Terwel, D., Vandezande, K., Lasrado, R., Bruynseels, K., Irizarry, M. C., Verhoye, M., Lint, J. V., et al. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00236-1 · Cited by 103 · see citing works
Salas, T. R., Reddy, S. A. G., Clifford, J. L., Davis, R. J., Kikuchi, A., Lippman, S. M., & Menter, D. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302972200 · Cited by 70 · see citing works
Scheepens, A., van de Waarenburg, M. P. H., van den Hove, D., & Blanco, C. E. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.043414 · Cited by 65 · see citing works
Gozes, I., Bachar, M., Bardea, A., Davidson, A., Rubinraut, S., Fridkin, M., & Giladi, E. (1997) · Journal of Neurobiology · doi:10.1002/(sici)1097-4695(199709)33:3 · Cited by 63 · see citing works
Signal Transduction and Genes-to-Behaviors Pathways in Psychiatric Diseases
Manji, H. K., Gottesman, I. I., & Gould, T. D. (2003) · Science s STKE · doi:10.1126/stke.2003.207.pe49 · Cited by 63 · see citing works
Glycogen synthase kinase-3 as drug target: From wallflower to center of attention
Wauwe, J. V., & Haefner, B. (2003) · Drug News & Perspectives · doi:10.1358/dnp.2003.16.9.829337 · Cited by 60 · see citing works
Klamer, D., P�lsson, E., Revesz, A., Engel, J. A., & Svensson, L. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1901-z · Cited by 57 · see citing works
Dysregulation of Striatal Dopamine Signaling by Amphetamine Inhibits Feeding by Hungry Mice
Cannon, C. M., Abdallah, L., Tecott, L. H., During, M. J., & Palmiter, R. D. (2004) · Neuron · doi:10.1016/j.neuron.2004.10.009 · Cited by 54 · see citing works
The effect of lithium administration in animal models of depression: a short review
Redrobe, J. P., & Bourin, M. (1999) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.1999.tb00348.x · Cited by 32 · see citing works
[Schizophrenia and eating disorders].
Foulon, C. (2004) · PubMed · Cited by 29 · see citing works
Lewis, M. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00213-2 · Cited by 12 · see citing works
Animal Models for the Symptoms of Mania
Lyon, M. (2003) · Humana Press eBooks · doi:10.1385/0-89603-198-5:197 · Cited by 8 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The physiology, signaling, and pharmacology of dopamine receptors
Beaulieu, J.-M., & Gainetdinov, R. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002642 · Cited by 2,763 · see citing works
Animal models of neuropsychiatric disorders
Nestler, E. J., & Hyman, S. E. (2010) · Nature Neuroscience · doi:10.1038/nn.2647 · Cited by 2,023 · see citing works
Circadian genes, rhythms and the biology of mood disorders
McClung, C. A. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.02.003 · Cited by 666 · see citing works
Dopamine receptors – IUPHAR R eview 13
Beaulieu, J., Espinoza, S., & Gainetdinov, R. R. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12906 · Cited by 528 · see citing works
Akt/GSK3 Signaling in the Action of Psychotropic Drugs
Beaulieu, J., Gainetdinov, R. R., & Caron, M. G. (2008) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.011008.145634 · Cited by 523 · see citing works
How might circadian rhythms control mood? Let me count the ways
McClung, C. A. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.02.019 · Cited by 507 · see citing works
GSK-3: Functional Insights from Cell Biology and Animal Models
Kaidanovich‐Beilin, O., & Woodgett, J. R. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00040 · Cited by 490 · see citing works
Potential Mechanisms of Action of Lithium in Bipolar Disorder
Malhi, G. S., Tanious, M., Das, P., Coulston, C. M., & Berk, M. (2013) · CNS Drugs · doi:10.1007/s40263-013-0039-0 · Cited by 464 · see citing works
Sex differences in animal models of psychiatric disorders
Kokras, N., & Dalla, C. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12710 · Cited by 418 · see citing works
The Akt–GSK-3 signaling cascade in the actions of dopamine
Beaulieu, J., Gainetdinov, R. R., & Caron, M. G. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.02.006 · Cited by 421 · see citing works
A β-arrestin 2 Signaling Complex Mediates Lithium Action on Behavior
Beaulieu, J., Marion, S., Rodriguiz, R. M., Medvedev, I. O., Sotnikova, T. D., Ghisi, V., Wetsel, W. C., Lefkowitz, R. J., Gainetdinov, R. R., & Caron, M. G. (2008) · Cell · doi:10.1016/j.cell.2007.11.041 · Cited by 362 · see citing works
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS
Eldar-Finkelman, H., & Martı́nez, A. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00032 · Cited by 356 · see citing works
Neuroplasticity Mediated by Altered Gene Expression
McClung, C. A., & Nestler, E. J. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301544 · Cited by 347 · see citing works
What Are the bona fide GSK3 Substrates?
Sutherland, C. D. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/505607 · Cited by 349 · see citing works
van den Buuse, M. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp132 · Cited by 340 · see citing works
Masri, B., Salahpour, A., Didriksen, M., Ghisi, V., Beaulieu, J., Gainetdinov, R. R., & Caron, M. G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803522105 · Cited by 320 · see citing works
GSK-3 and tau: a key duet in Alzheimer’s disease
Sayas, C. L., & Ávila, J. (2021) · Cells · doi:10.3390/cells10040721 · Cited by 314 · see citing works
Is Glycogen Synthase Kinase-3 a Central Modulator in Mood Regulation?
Li, X., & Jope, R. S. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.105 · Cited by 294 · see citing works
Roles of the Akt/GSK-3 and Wnt Signaling Pathways in Schizophrenia and Antipsychotic Drug Action
Freyberg, Z., Ferrando, S. J., & Javitch, J. A. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.08121873 · Cited by 288 · see citing works
Review of Lithium Effects on Brain and Blood
Young, W. (2009) · Cell Transplantation · doi:10.3727/096368909x471251 · Cited by 287 · see citing works
What's wrong with my mouse model?
Kalueff, A. V., Wheaton, M., & Murphy, D. L. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.01.023 · Cited by 285 · see citing works
Cellular Plasticity Cascades in the Pathophysiology and Treatment of Bipolar Disorder
Schloesser, R. J., Huang, J. Y., Klein, P. S., & Manji, H. K. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301575 · Cited by 256 · see citing works
Beaulieu, J. (2011) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.110011 · Cited by 237 · see citing works
Sex differences in antidepressant efficacy
LeGates, T. A., Kvarta, M. D., & Thompson, S. M. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0156-z · Cited by 225 · see citing works
5-HT1A receptor-regulated signal transduction pathways in brain
Polter, A. M., & Li, X. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.03.019 · Cited by 225 · see citing works
Chiu, C., & Chuang, D. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.07.006 · Cited by 226 · see citing works
Polter, A., Beurel, E., Yang, S., Garner, R., Song, L., Miller, C. A., Sweatt, J. D., McMahon, L., Bartolucci, A. A., Li, X., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.43 · Cited by 225 · see citing works
Novel Drugs and Therapeutic Targets for Severe Mood Disorders
Mathew, S. J., Manji, H. K., & Charney, D. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301652 · Cited by 222 · see citing works
Identifying blood biomarkers for mood disorders using convergent functional genomics
Le-Niculescu, H., Kurian, S. M., Yehyawi, N., Dike, C., Patel, S. D., Edenberg, H. J., Tsuang, M. T., Salomon, D. R., Nürnberger, J. I., & Niculescu, A. B. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.11 · Cited by 211 · see citing works
Clock genes may influence bipolar disorder susceptibility and dysfunctional circadian rhythm
Shi, J., Wittke‐Thompson, J. K., Badner, J. A., Hattori, E., Potash, J. B., Willour, V. L., McMahon, F. J., Gershon, E. S., & Liu, C. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30714 · Cited by 211 · see citing works
Vadnie, C. A., & McClung, C. A. (2017) · Neural Plasticity · doi:10.1155/2017/1504507 · Cited by 199 · see citing works
Xing, B., Li, Y.-C., & Gao, W.-J. (2016) · Brain Research · doi:10.1016/j.brainres.2016.01.005 · Cited by 196 · see citing works
Yuskaitis, C. J., Mines, M. A., King, M. K., Sweatt, J. D., Miller, C. A., & Jope, R. S. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.09.023 · Cited by 187 · see citing works
The circadian basis of mood disorders: Recent developments and treatment implications
Monteleone, P., & Maj, M. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.06.007 · Cited by 185 · see citing works
GSK‐3 in Neurodegenerative Diseases
Lei, P., Ayton, S., Bush, A. I., & Adlard, P. A. (2011) · International Journal of Alzheimer’s Disease · doi:10.4061/2011/189246 · Cited by 177 · see citing works
Abnormalities in brain structure and behavior in GSK-3alpha mutant mice
Kaidanovich‐Beilin, O., Lipina, T. V., Takao, K., van Eede, M., Hattori, S., Laliberté, C. L., Khan, M., Okamoto, K., Chambers, J. W., Fletcher, P. J., et al. (2009) · Molecular Brain · doi:10.1186/1756-6606-2-35 · Cited by 176 · see citing works
Glycogen Synthase Kinase-3 in the Etiology and Treatment of Mood Disorders
Jope, R. S. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00016 · Cited by 174 · see citing works
Shaltiel, G., Maeng, S., Malkesman, O., Pearson, B., Schloesser, R. J., Tragon, T., Rogawski, M., Gasior, M., Luckenbaugh, D., Chen, G., et al. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.20 · Cited by 173 · see citing works
Mármol, F. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.08.012 · Cited by 174 · see citing works
Circadian rhythms and mood regulation: insights from pre-clinical models
McClung, C. A. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.07.008 · Cited by 169 · see citing works
Dao, D. T., Mahon, P. B., Cai, X., Kovacsics, C. E., Blackwell, R. A., Arad, M., Shi, J., Zandi, P. P., O’Donnell, P., Knowles, J. A., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.019 · Cited by 168 · see citing works
GSK3 Function in the Brain during Development, Neuronal Plasticity, and Neurodegeneration
Salcedo‐Tello, P., Ortiz‐Matamoros, A., & Arias, C. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/189728 · Cited by 163 · see citing works
Wnts in adult brain: from synaptic plasticity to cognitive deficiencies
Oliva, C. A., Vargas, J. Y., & Inestrosa, N. C. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00224 · Cited by 162 · see citing works
Circadian rhythms and treatment implications in depression
Monteleone, P., Martiadis, V., & Maj, M. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.028 · Cited by 165 · see citing works
GSK-3β at the Intersection of Neuronal Plasticity and Neurodegeneration
Jaworski, T., Banach, E., & Gralec, K. (2019) · Neural Plasticity · doi:10.1155/2019/4209475 · Cited by 161 · see citing works
Beyond cAMP: the regulation of Akt and GSK3 by dopamine receptors
Beaulieu, J. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00038 · Cited by 159 · see citing works
Validating GSK3 as an in vivo target of lithium action
O'Brien, W. T., & Klein, P. S. (2009) · Biochemical Society Transactions · doi:10.1042/bst0371133 · Cited by 157 · see citing works
Lithium: the pharmacodynamic actions of the amazing ion
Brown, K. M., & Tracy, D. K. (2013) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125312471963 · Cited by 140 · see citing works
GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder
Rowe, M. K., Wiest, C., & Chuang, D. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.03.002 · Cited by 142 · see citing works
McCarthy, M. J., Wei, H., Marnoy, Z., Darvish, R. M., McPhie, D. L., Cohen, B. M., & Welsh, D. K. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.90 · Cited by 137 · see citing works
McCarthy, M. J., Gottlieb, J. F., Gonzalez, R., McClung, C. A., Alloy, L. B., Cain, S., Dulcis, D., Etain, B., Frey, B. N., Garbazza, C., et al. (2022) · Bipolar Disorders · doi:10.1111/bdi.13165 · Cited by 136 · see citing works
Animal models of bipolar mania: The past, present and future
Logan, R. W., & McClung, C. A. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.08.041 · Cited by 136 · see citing works
Holm, T. H., & Lykke‐Hartmann, K. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00209 · Cited by 134 · see citing works
Predictive animal models of mania: hits, misses and future directions
Young, J. W., Henry, B. L., & Geyer, M. A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01318.x · Cited by 131 · see citing works
Evidence that glycogen synthase kinase‐3 isoforms have distinct substrate preference in the brain
Soutar, M. P. M., Kim, W.-Y., Williamson, R., Peggie, M. W., Hastie, C. J., McLauchlan, H., Snider, W. D., Gordon‐Weeks, P. R., & Sutherland, C. D. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06988.x · Cited by 130 · see citing works
Glycogen Synthase Kinase-3 Inhibitors: Preclinical and Clinical Focus on CNS-A Decade Onward
Ruiz, S. M. A., & Eldar-Finkelman, H. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.792364 · Cited by 126 · see citing works
Wada, A. (2009) · Journal of Pharmacological Sciences · doi:10.1254/jphs.09r02cr · Cited by 128 · see citing works
Increase in GSK3β gene copy number variation in bipolar disorder
Lachman, H. M., Pedrosa, E., Petruolo, O. A., Cockerham, M. S., Papolos, A., Novák, T., Papolos, D. F., & Stopková, P. (2007) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30498 · Cited by 127 · see citing works
Review of Pharmacological Treatment in Mood Disorders and Future Directions for Drug Development
Li, X., Frye, M. A., & Shelton, R. C. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.198 · Cited by 127 · see citing works
Aripiprazole, A Drug that Displays Partial Agonism and Functional Selectivity
Tuplin, E. W. N., & Holahan, M. R. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170413115754 · Cited by 124 · see citing works
Deletion of Glutamate Delta-1 Receptor in Mouse Leads to Aberrant Emotional and Social Behaviors
Yadav, R., Gupta, S. C., Hillman, B. G., Bhatt, J. M., Stairs, D. J., & Dravid, S. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032969 · Cited by 123 · see citing works
Targeting GSK3 signaling as a potential therapy of neurodegenerative diseases and aging
Duda, P., Wiśniewski, J., Wójtowicz, T., Wójcicka, O., Jaskiewicz, M. R., Drulis‐Fajdasz, D., Rakus, D., McCubrey, J. A., & Gizak, A. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1526925 · Cited by 121 · see citing works
The impact of Disrupted-in-Schizophrenia 1 (DISC1) on the dopaminergic system: a systematic review
Dahoun, T., Trossbach, S. V., Brandon, N., Korth, C., & Howes, O. (2017) · Translational Psychiatry · doi:10.1038/tp.2016.282 · Cited by 118 · see citing works
Molecular actions and clinical pharmacogenetics of lithium therapy
Can, A., Schulze, T. G., & Gould, T. D. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.02.004 · Cited by 121 · see citing works
Functions of GSK-3 Signaling in Development of the Nervous System
Kim, W. Y., & Snider, W. D. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00044 · Cited by 121 · see citing works
Molecular Mechanisms of Bipolar Disorder: Progress Made and Future Challenges
Kim, Y., Santos, R., Gage, F. H., & Marchetto, M. C. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00030 · Cited by 120 · see citing works
Assessment of circadian function in fibroblasts of patients with bipolar disorder
Yang, S., Van Dongen, H. P. A., Wang, K., Berrettini, W., & Bućan, M. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.10 · Cited by 113 · see citing works
Growth factors as clinical biomarkers of prognosis and diagnosis in psychiatric disorders
Galvez-Contreras, A. Y., Campos-Ordonez, T., Lopez-Virgen, V., Gomez-Plascencia, J., Ramos-Zuniga, R., & Gonzalez-Perez, O. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.08.004 · Cited by 112 · see citing works
Scaini, G., Valvassori, S. S., Díaz, A. P., Lima, C. N. D. C., Benevenuto, D., Fries, G. R., & Quevedo, J. (2020) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2019-0732 · Cited by 114 · see citing works
O’Brien, W. T., Huang, J. Y., Buccafusca, R., Garskof, J., Valvezan, A. J., Berry, G. T., & Klein, P. S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45194 · Cited by 109 · see citing works
AKT Kinase Activity Is Required for Lithium to Modulate Mood-Related Behaviors in Mice
Pan, J. Q., Lewis, M. C., Ketterman, J. K., Clore, E. L., Riley, M. M., Richards, K. R., Berry-Scott, E., Liu, X., Wagner, F. F., Holson, E. B., et al. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.24 · Cited by 109 · see citing works
Animal models for bipolar disorder: from bedside to the cage
Beyer, D. K. E., & Freund, N. (2017) · International Journal of Bipolar Disorders · doi:10.1186/s40345-017-0104-6 · Cited by 110 · see citing works
TNiK Is Required for Postsynaptic and Nuclear Signaling Pathways and Cognitive Function
Coba, M. P., Komiyama, N. H., Nithianantharajah, J., Kopanitsa, M. V., Indersmitten, T., Skene, N., Tuck, E. J., Fricker, D. G., Elsegood, K. A., Stanford, L. E., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2433-12.2012 · Cited by 106 · see citing works
Sleep- and circadian rhythm–associated pathways as therapeutic targets in bipolar disorder
Bellivier, F., Geoffroy, P.-A., Etain, B., & Scott, J. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2015.1018822 · Cited by 104 · see citing works
Mechanisms and Therapeutic Implications of GSK-3 in Treating Neurodegeneration
Rippin, I., & Eldar-Finkelman, H. (2021) · Cells · doi:10.3390/cells10020262 · Cited by 102 · see citing works
Molecular neurobiology of bipolar disorder: a disease of ‘mood-stabilizing neurons’?
Kato, T. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.07.007 · Cited by 102 · see citing works
Watkins, C. C., Sawa, A., & Pomper, M. G. (2014) · Translational Psychiatry · doi:10.1038/tp.2013.119 · Cited by 100 · see citing works
Бычков, Э. Р., Ahmed, M. R., & Gurevich, E. V. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000118 · Cited by 99 · see citing works
Preclinical efficacy on GSK‐3 inhibitors: Towards a future generation of powerful drugs
Martı́nez, A. (2008) · Medicinal Research Reviews · doi:10.1002/med.20119 · Cited by 98 · see citing works
Griebel, G., Stemmelin, J., Lopez-Grancha, M., Boulay, D., Boquet, G., Slowinski, F., Pichat, P., Beeské, S., Tanaka, S., Mori, A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-54557-5 · Cited by 97 · see citing works
A new look at an old drug: neuroprotective effects and therapeutic potentials of lithium salts
Carmassi, C., Grande, C. D., Gesi, C., Musetti, L., & Dell’Osso, L. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s106479 · Cited by 97 · see citing works
Wnt Signaling in the Central Nervous System: New Insights in Health and Disease
Oliva, C. A., Montecinos-Oliva, C., & Inestrosa, N. C. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.11.018 · Cited by 97 · see citing works
Brand, S., Moller, M., & Harvey, B. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150307004545 · Cited by 95 · see citing works
Translational research in bipolar disorder: emerging insights from genetically based models
Chen, G., Henter, I. D., & Manji, H. K. (2010) · Molecular Psychiatry · doi:10.1038/mp.2010.3 · Cited by 95 · see citing works
Boulle, F., Massart, R., Stragier, E., Païzanis, E., Zaidan, L., Marday, S., Gabriel, C., Mocaer, E., Mongeau, R., & Lanfumey, L. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.125 · Cited by 91 · see citing works
Wnt/β‐catenin signaling in brain development and mental disorders: keeping TCF7L2 in mind
Bem, J., Brożko, N., Chakraborty, C., Lipiec, M. A., Koziński, K., Nagalski, A., Szewczyk, Ł. M., & Wisniewska, M. B. (2019) · FEBS Letters · doi:10.1002/1873-3468.13502 · Cited by 94 · see citing works
Dewachter, I., Ris, L., Jaworski, T., Seymour, C. M., Kremer, A., Borghgraef, P., Vijver, H. D., Godaux, E., & LEUVEN, F. V. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.04.003 · Cited by 94 · see citing works
Urs, N. M., Snyder, J. C., Jacobsen, J. P. R., Peterson, S. M., & Caron, M. G. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215489109 · Cited by 91 · see citing works
Wnt signaling: Role in LTP, neural networks and memory
Oliva, C. A., Vargas, J., & Inestrosa, N. C. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.03.006 · Cited by 90 · see citing works
Genetic and pharmacological evidence for schizophrenia‐related Disc1 interaction with GSK‐3
Lipina, T. V., Kaidanovich‐Beilin, O., Patel, S., Wang, M., Clapcote, S. J., Liu, F., Woodgett, J. R., & Roder, J. (2010) · Synapse · doi:10.1002/syn.20839 · Cited by 91 · see citing works
Functional Selectivity and Antidepressant Activity of Serotonin 1A Receptor Ligands
Chilmończyk, Z., Bojarski, A. J., Pilc, A., & Sylte, I. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160818474 · Cited by 89 · see citing works
Regulation of glycogen synthase kinase‐3 during bipolar mania treatment
Li, X., Liu, M., 蔡卓基, Wang, G., & Li, X. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00866.x · Cited by 86 · see citing works
Circadian Clocks and Mood-Related Behaviors
Albrecht, U. (2013) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25950-0_9 · Cited by 86 · see citing works
Wnt signaling in neuropsychiatric disorders: Ties with adult hippocampal neurogenesis and behavior
Hussaini, S. M. Q., Choi, C., Cho, C. H., Kim, H. J., Jun, H., & Jang, M. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.09.005 · Cited by 84 · see citing works
de Smith, A. J., Walters, R. G., Froguel, P., & Blakemore, A. I. F. (2008) · Cytogenetic and Genome Research · doi:10.1159/000184688 · Cited by 84 · see citing works
GSK3β: a master player in depressive disorder pathogenesis and treatment responsiveness
Duda, P., Hajka, D., Wójcicka, O., Rakus, D., & Gizak, A. (2020) · Cells · doi:10.3390/cells9030727 · Cited by 84 · see citing works
Viggiano, D. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.06.033 · Cited by 82 · see citing works
Latapy, C., Rioux, V., Guitton, M. J., & Beaulieu, J. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2012.0094 · Cited by 82 · see citing works
Takao, K., Yamasaki, N., & Miyakawa, T. (2007) · Neuroscience Research · doi:10.1016/j.neures.2007.02.009 · Cited by 81 · see citing works
Novel Treatment Strategies Targeting Myelin and Oligodendrocyte Dysfunction in Schizophrenia
Junqueira, D. G., Falvella, A. C. B., Antunes, A. S. L. M., Seabra, G., Brandão‐Teles, C., Martins‐de‐Souza, D., & Crunfli, F. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00379 · Cited by 80 · see citing works
- Authors
- Prickaerts, J., Moechars, D., Cryns, K., Lenaerts, I., van Craenendonck, H., Goris, I., Daneels, G., Bouwknecht, J. A., & Steckler, T.
- Affiliations
- Janssen Research & Development (United States) (US)
- Corresponding author
- Steckler, Thomas
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2006-08-30
- Volume
- 26
- Issue
- 35
- Pages
- 9022-9029
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6675350
- OpenAlex
- W1963600261
- Cited by
- 341
- References
- 59
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 7 · 2023: 7 · 2022: 13 · 2021: 14 · 2020: 17 · 2019: 7 · 2018: 11 · 2017: 13 · 2016: 22 · 2015: 20 · 2014: 27 · 2013: 27 · 2012: 21
- FWCI
- 11.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, cc-by-nc-sa)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Funders
- European Commission
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Keywords
- glycogen synthase kinase-3β, transgenic mice, hyperactivity, mania, bipolar disorder, lithium, AKT1, brain-derived neurotrophic factor, striatum, hippocampus, locomotor activity, acoustic startle response, habituation, ACTH, compensatory signaling, neuroplasticity
- MeSH terms
- Glycogen Synthase Kinase 3 beta, Adrenocorticotropic Hormone, Animals, Bipolar Disorder, Corticosterone, Disease Models, Animal, DNA, Drinking, Eating, Female, Hippocampus, Hyperkinesis, Male, Mice, Transgenic, Motor Activity, Reflex, Startle, Swimming, Signal Transduction, Photoperiod, Brain-Derived Neurotrophic Factor, Glycogen Synthase Kinase 3, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
